Life Expectancy at Birth (2019)
  – Male: 76.3; Female: 81.9; Both Genders: 79.1
Maternal Mortality Ratio (per 100,000 live births) (2017): 3
Neonatal Mortality Rate (per 1,000 live births) (2019): 2
Probability of Dying from any of Cardiovascular Disease, Cancer, Diabetes, Chronic Respiratory Diseases Between Age 30 and Exact Age 70 (%) (2019): 14.3%

Source: World health statistics 2021: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.

Neonatal Mortality Rate (Deaths Per 1,000 Live Births) (2019): 2
Infant Mortality Rate (Deaths Per 1,000 Live Births) (2019): 3
Under-5 Mortality Rate (Deaths Per 1,000 Live Births) (2019):
  Male: 4; Female: 3

Note: “Under-5 mortality rate – Probability of dying between birth and exactly 5 years of age, expressed per 1,000 live births.
“Infant mortality rate – Probability of dying between birth and exactly 1 year of age, expressed per 1,000 live births.
“Neonatal mortality rate – Probability of dying during the first 28 days of life, expressed per 1,000 live births.”

Source: United Nations Children’s Fund, The State of the World’s Children 2021: On My Mind – Promoting, protecting and caring for children’s mental health, UNICEF, New York, October 2021.

“In 2020, life expectancy at birth in Czechia was 78.3 years, which is 2.3 years below the EU average, although it was among the highest in central and eastern European countries (Figure 1). It increased by more than three years between 2000 and 2020. The gender gap in life expectancy was six years, which is higher than the EU average (5.6 years).

“In 2019, there was a substantial difference between the capital region of Prague and the rest of the country, and smaller variations across regions. For instance, life expectancy for men living in Prague was more than 4.0 years higher than for men living in the Ústecký region.”

OECD/European Observatory on Health Systems and Policies (2021), Czechia: Country Health Profile 2021, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.

“Previous increases in life expectancy between 2000 and 2019 in Czechia can be attributed mainly to reductions in mortality from leading causes of death.

“Notably, the standardised death rate from circulatory diseases decreased by almost 40%, reflecting in part the concentration of highly specialised cardiology and stroke care into centres set up in 2011 (see Section 4). However, circulatory diseases still accounted for over 40% of all deaths in Czechia in 2019, while cancer accounted for another 25% (Figure 2). Lung cancer remained the most frequent cause of death by cancer. Diabetes is another notable cause of death in Czechia: its standardised death rate is the fourth highest across the EU.

“In 2020, COVID-19 officially accounted for about 12,000 deaths in Czechia (9.2% of all deaths), rising to 30,400 by the end of August 2021. By then, the COVID-19 mortality rate was almost 80% higher than the EU average (2,843 per million compared with 1,591 in the EU). The broader indicator of excess mortality suggests that the direct and indirect death toll related to COVID-19 in 2020 might have been even higher (Box 1).”

OECD/European Observatory on Health Systems and Policies (2021), Czechia: Country Health Profile 2021, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels.

Health Systems Facts is a project of the Real Reporting Foundation. We provide reliable statistics and other data from authoritative sources regarding health systems in the US and several other nations.

Page last updated March 10, 2022 by Doug McVay, Editor.